Samantha Maurotti
Overview
Explore the profile of Samantha Maurotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Coppola A, Chuquitaype M, Guglielmo S, Pujia R, Ferrulli A, Falcone C, et al.
Endocrine
. 2024 Jul;
86(3):1202.
PMID: 39046594
No abstract available.
12.
Afzal M, Greco F, Quinzi F, Scionti F, Maurotti S, Montalcini T, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 38999923
Exercise may differently affect the expression of key molecular markers, including skeletal muscle and circulating miRNAs, involved in cellular and metabolic pathways' regulation in healthy individuals and in patients suffering...
13.
Maurotti S, Geirola N, Frosina M, Mirarchi A, Scionti F, Mare R, et al.
Front Cell Dev Biol
. 2024 May;
12:1404006.
PMID: 38818407
Over the past 10 years, the biological role of lipid droplets (LDs) has gained significant attention in the context of both physiological and pathological conditions. Considerable progress has been made...
14.
De Caro C, Spagnuolo R, Quirino A, Mazza E, Carrabetta F, Maurotti S, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791490
Gut microbiota imbalances have a significant role in the pathogenesis of Inflammatory Bowel Disease (IBD) and Non-Alcoholic Fatty Liver Disease (NAFLD). Herein, we compared gut microbial composition in patients diagnosed...
15.
Caddeo A, Maurotti S, Kovooru L, Romeo S
Atherosclerosis
. 2024 Apr;
393:117544.
PMID: 38677899
Steatotic liver disease (SLD) refers to a spectrum of diseases caused by hepatic lipid accumulation. SLD has emerged as the leading cause of chronic liver disease worldwide. Despite this burden...
16.
Coppola A, Chuquitaype M, Guglielmo S, Pujia R, Ferrulli A, Falcone C, et al.
Endocrine
. 2024 Apr;
86(1):127-134.
PMID: 38656749
Purpose: The aim of this study is to prospectively evaluate whether individual and group Therapeutic Patient Education (TPE) can reduce the need to intensify treatment of diabetes and hypertension in...
17.
Mazza E, Ferro Y, Maurotti S, Micale F, Boragina G, Russo R, et al.
Eur J Nutr
. 2024 Apr;
63(5):1651-1662.
PMID: 38568294
Purpose: Although numerous studies have investigated the impact of dietary factors on the prevention of decreased muscle mass and function, limited research has examined the relationship between dietary patterns and...
18.
Greco F, Tarsitano M, Cosco L, Quinzi F, Folino K, Spadafora M, et al.
Nutrients
. 2024 Mar;
16(6).
PMID: 38542813
Diet and exercise intervention are the first strategies to counteract obesity. An online home-based exercise program may be a feasible approach in an obese population. Therefore, this study aimed to...
19.
De Vincentis A, Tavaglione F, Namba S, Kanai M, Okada Y, Kamatani Y, et al.
Aliment Pharmacol Ther
. 2024 Mar;
59(11):1402-1412.
PMID: 38497224
Background And Aims: The European Association for the Study of the Liver introduced a clinical pathway (EASL CP) for screening significant/advanced fibrosis in people at risk of steatotic liver disease...
20.
Romeo S, Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, et al.
Res Sq
. 2024 Feb;
PMID: 38405802
Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses an excess of triglycerides in the liver, which can lead to cirrhosis and liver cancer. While there is solid epidemiological evidence of MASLD...